Basket | Login


Management approach

Who are the PharmaCog partners?

Pharmacog Logo

The Project Coordinator is the intermediary between the Innovative Medicine Initiative Joint Undertaking (IMI-JU) and the consortium in all scientific and industry related concerns. The Managing Entity is the second intermediary between the IMI-JU and the Consortium and is concerned with contractual and funding related matters concerning the participating academic institutions and SMEs. Each Work Package has a leader and a co-leader from academic institution or industry. They are jointly responsible for the milestones and deliverables of their WP and for engaging and communicating with all the partners in the project.



Last Updated: Monday 14 November 2011


  • Acknowledgements

    The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) for the Innovative Medicine Initiative under Grant Agreement No 115009.
  • Innovative Medicines Initiative
  • European Union
  • European Federation of Pharmaceutical Industries and Associations